-
Mashup Score: 1
Decades of declining heart failure mortality in the U.S. has reversed, and exceeded rates recorded more than 20 years ago, according to overall population-level data published in JAMA Cardiology.“Recent data suggest plateaus or reversals after long-standing declines in cardiovascular mortality, particularly for HF-related mortality,” Ahmed Sayed, MBBS, of the faculty of medicine at
Source: www.healio.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 1
Decades of declining heart failure mortality in the U.S. has reversed, and exceeded rates recorded more than 20 years ago, according to overall population-level data published in JAMA Cardiology.“Recent data suggest plateaus or reversals after long-standing declines in cardiovascular mortality, particularly for HF-related mortality,” Ahmed Sayed, MBBS, of the faculty of medicine at
Source: www.healio.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 1
Decades of declining heart failure mortality in the U.S. has reversed, and exceeded rates recorded more than 20 years ago, according to overall population-level data published in JAMA Cardiology.“Recent data suggest plateaus or reversals after long-standing declines in cardiovascular mortality, particularly for HF-related mortality,” Ahmed Sayed, MBBS, of the faculty of medicine at
Source: www.healio.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 1
Decades of declining heart failure mortality in the U.S. has reversed, and exceeded rates recorded more than 20 years ago, according to overall population-level data published in JAMA Cardiology.“Recent data suggest plateaus or reversals after long-standing declines in cardiovascular mortality, particularly for HF-related mortality,” Ahmed Sayed, MBBS, of the faculty of medicine at
Source: www.healio.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 7
Bayer AG and its subsidiary Asklepios BioPharmaceutical announced the FDA granted fast track designation for its investigational gene therapy for the treatment of congestive heart failure. The fast track designation is granted to therapies with the potential to fill unmet needs of patients with serious medical conditions. It includes the ability for the developer to have more frequent
Source: www.healio.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 49Sodium–glucose cotransporter 2 inhibitors influence skeletal muscle pathology in patients with heart failure and reduced ejection fraction - 2 month(s) ago
European Journal of Heart Failure is an ESC journal dedicated to improving the understanding, prevention, investigation and treatment of heart failure.
Source: onlinelibrary.wiley.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 4Q&A: Considerations for sustaining advancement of durable mechanical circulatory support - 2 month(s) ago
Since the implant of the first left ventricular assist device in 1994, the HF community observed significant technological innovation in durable mechanical circulatory support.Advancements include innovations in pump design, perioperative and long-term management of patients on durable mechanical circulatory support.
Source: www.healio.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 45Sodium–glucose cotransporter 2 inhibitors influence skeletal muscle pathology in patients with heart failure and reduced ejection fraction - 2 month(s) ago
European Journal of Heart Failure is an ESC journal dedicated to improving the understanding, prevention, investigation and treatment of heart failure.
Source: onlinelibrary.wiley.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 2
A short-stay strategy designed to lower cost of care may improve quality of life of low-risk patients with acute HF in the ED, but the trial was underpowered due to low enrollment during the COVID-19 pandemic, researchers reported.The results of the multicenter randomized SSU-AHF trial were published in JAMA Network Open.
Source: www.healio.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 2
A short-stay strategy designed to lower cost of care may improve quality of life of low-risk patients with acute HF in the ED, but the trial was underpowered due to low enrollment during the COVID-19 pandemic, researchers reported.The results of the multicenter randomized SSU-AHF trial were published in JAMA Network Open.
Source: www.healio.comCategories: General Medicine News, Cardiology News and JournTweet
Decades of declining #heartfailure mortality in the U.S. has reversed, and exceeded rates recorded more than 20 years ago, according to overall population-level data published in @JAMACardio #Cardiotwitter Read more👇 https://t.co/x7B75viq61